^
Association details:
Biomarker:No biomarker
Cancer:Breast Cancer
Drug:exemestane (Aromatase inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A1 - Approval
New
Source:
Excerpt:
AROMASIN is an aromatase inhibitor indicated for:...treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy…